These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
506 related articles for article (PubMed ID: 29271065)
1. Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4). Bookhout C; Bouldin TW; Ellison DW Neuropathology; 2018 Jun; 38(3):305-308. PubMed ID: 29271065 [TBL] [Abstract][Full Text] [Related]
2. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. Hasselblatt M; Gesk S; Oyen F; Rossi S; Viscardi E; Giangaspero F; Giannini C; Judkins AR; Frühwald MC; Obser T; Schneppenheim R; Siebert R; Paulus W Am J Surg Pathol; 2011 Jun; 35(6):933-5. PubMed ID: 21566516 [TBL] [Abstract][Full Text] [Related]
3. Loss of BRG1 ( Saunders J; Ingley K; Wang XQ; Harvey M; Armstrong L; Ng T; Dunham C; Bush J Pediatr Dev Pathol; 2020; 23(2):132-138. PubMed ID: 31403913 [TBL] [Abstract][Full Text] [Related]
4. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases. Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994 [TBL] [Abstract][Full Text] [Related]
5. [Central nervous system atypical teratoid/rhabdoid tumor without loss of nuclear expression of INI1]. Ryzhova MV; Kadyrov SU; Kumirova EV; Shishkina LV; Nikitin PV; Panina TN; Shibaeva IV; Shugay SV; Starovoytov DV; Sycheva RV; Zubova IV Arkh Patol; 2019; 81(2):36-42. PubMed ID: 31006778 [TBL] [Abstract][Full Text] [Related]
6. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology. Ramalingam P; Croce S; McCluggage WG Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868 [TBL] [Abstract][Full Text] [Related]
7. SMARCB1 (INI1) retained but SMARCA4 (BRG1) negative atypical teratoid/rhabdoid tumor arising at the bilateral cerebellopontine angles: a case report. Mitsui N; Oikawa K; Tanino M; Kinoshita M J Surg Case Rep; 2021 Sep; 2021(9):rjab400. PubMed ID: 34611487 [TBL] [Abstract][Full Text] [Related]
8. An infantile pineal embryonal tumor showing pathological features of a CNS ganglioneuroblastoma and the methylation profiling of an atypical teratoid/rhabdoid tumor and SMARCA4 mutation. Fukuoka K; Nakazawa A; Hirato J; Nobusawa S; Itabashi T; Arakawa Y; Mori M; Matsushita Y; Honda S; Tanami Y; Ichimura K; Kurihara J; Koh K J Neuropathol Exp Neurol; 2023 Jun; 82(7):664-667. PubMed ID: 37086056 [No Abstract] [Full Text] [Related]
9. Spontaneous Regression of Atypical Teratoid Rhabdoid Tumor Without Therapy in a Patient With Uncommon Regional Inactivation of SMARCB1 ( hSNF5/INI1). Peterson JEG; Bavle A; Mehta VP; Rauch RA; Whitehead WE; Mohila CA; Su JM; Adesina AM Pediatr Dev Pathol; 2019; 22(2):161-165. PubMed ID: 30470167 [TBL] [Abstract][Full Text] [Related]
10. SWI/SNF-deficient tumors of the central nervous system: An update. Hasselblatt M; Kool M; Frühwald MC Clin Neuropathol; 2024; 43(1):2-9. PubMed ID: 37969088 [TBL] [Abstract][Full Text] [Related]
13. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant. Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939 [TBL] [Abstract][Full Text] [Related]
14. Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Schneppenheim R; Frühwald MC; Gesk S; Hasselblatt M; Jeibmann A; Kordes U; Kreuz M; Leuschner I; Martin Subero JI; Obser T; Oyen F; Vater I; Siebert R Am J Hum Genet; 2010 Feb; 86(2):279-84. PubMed ID: 20137775 [TBL] [Abstract][Full Text] [Related]
15. Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor. Thomas C; Oehl-Huber K; Bens S; Soschinski P; Koch A; Nemes K; Oyen F; Kordes U; Kool M; Frühwald MC; Hasselblatt M; Siebert R Genes Chromosomes Cancer; 2021 Aug; 60(8):586-590. PubMed ID: 33896072 [TBL] [Abstract][Full Text] [Related]
16. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors. Tegeder I; Thiel K; Erkek S; Johann PD; Berlandi J; Thatikonda V; Frühwald MC; Kool M; Jeibmann A; Hasselblatt M J Neurooncol; 2019 Jan; 141(1):43-55. PubMed ID: 30446899 [TBL] [Abstract][Full Text] [Related]
17. Concurrent myeloid sarcoma, atypical teratoid/rhabdoid tumor, and hypereosinophilia in an infant with a germline SMARCB1 mutation. Metts JL; Park SI; Soares BP; Fong C; Biegel JA; Goldsmith KC Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28111898 [TBL] [Abstract][Full Text] [Related]
18. Genomic Alterations in Undifferentiated Malignant Tumors with Rhabdoid Phenotype and Loss of BRG1 Immunoexpression Identified by Fine Needle Aspirates. Mei L; Alikhan M; Mujacic I; Parilla M; Antic T Acta Cytol; 2019; 63(5):438-444. PubMed ID: 31230044 [TBL] [Abstract][Full Text] [Related]
19. Malignant brain tumor in an infant showing histopathological features of yolk sac tumor but genetic and epigenetic features of AT/RT. Nakano Y; Satomi K; Okada K; Gotoh M; Ushiama M; Sakamoto H; Yoshida T; Kunihiro N; Hira K; Fukushima H; Inoue T; Hirato J; Ichimura K; Hara J Pediatr Blood Cancer; 2021 Sep; 68(9):e29192. PubMed ID: 34185381 [TBL] [Abstract][Full Text] [Related]
20. Atypical teratoid/rhabdoid tumor in adults: a systematic review of the literature with meta-analysis and additional reports of 4 cases. Broggi G; Gianno F; Shemy DT; Massimino M; Milanaccio C; Mastronuzzi A; Rossi S; Arcella A; Giangaspero F; Antonelli M J Neurooncol; 2022 Mar; 157(1):1-14. PubMed ID: 35217948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]